Work

Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type

Year: 2024
Type: article
Abstract: that is associated with poor outcomes.Efforts to improve
Source: eJHaem
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,600
OpenAlex ID: W4404859801
FWCI: 0.532
Cites: 10
Cited by: 2
Related to: 10